Skip to main content

BAM Wealth Management, LLC

SEC CIK
0002093649
Latest filing
Jul 14, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by BAM Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
6,175
Value
$483.3K
% of portfolio
0.3%
Quarters held
2
Since Q1 2026
Holdings of HALO by BAM Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,175$483.3K0.3%+1,691+37.7%AddedHolders
Q1 20264,484$289.8K0.2%+4,484NewHolders